Company Number: 14746407

Analysis Date: 2025-07-20 13:40 UTC

1. Credit Opinion: APPROVE – Dweepa UK Ltd is a recently incorporated private limited company operating in the general medical practice sector. Its first set of unaudited abridged accounts shows positive working capital and net assets, indicating a stable initial financial position. Despite limited operating history and scale (one employee), the absence of overdue filings, a single experienced director with full control, and prudent cash management support a favourable credit stance. However, credit limits should be modest given its infancy and limited financial track record.

2. Financial Strength: The balance sheet as at 31 March 2024 presents:

• Cash at bank: £13,300
• Current liabilities: £3,358
• Net current assets (working capital): £9,942
• Net assets/shareholders funds: £9,942
• Share capital: £100 The company shows a strong liquidity buffer relative to short-term creditors and positive equity. The small scale and single employee reflect a micro-entity profile, consistent with the account category. No fixed assets or long-term liabilities are reported, which reduces leverage risk. Overall, the financial position is sound for a first-year operation.

3. Cash Flow Assessment: Cash of £13,300 comfortably covers current liabilities of £3,358, yielding a current ratio of approximately 4:1, indicating strong short-term liquidity. The positive net current assets suggest good working capital management, though the company’s cash flow history is limited due to its recent formation. The single director and sole shareholder structure may facilitate efficient cash management decisions. Given the nature of the business (medical practice), predictable cash inflows may be expected as operations mature.

4. Monitoring Points:

• Revenue growth and profitability trends in subsequent accounting periods to establish sustainability.
• Maintenance of positive working capital and liquidity as operations scale.
• Any increases in liabilities or fixed asset investments that may affect financial flexibility.
• Timely submission of future accounts and confirmation statements.
• Monitor director conduct and company status for any changes.
• Potential impact of sector-specific risks such as regulatory changes or NHS contract variations.